• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»CSF diversion

Could CereVasc’s eShunt replace VP shunts in post-aneurysmal hydrocephalus treatment?

By Pallavi Madhiraju on January 26, 2026   Medical Devices & Diagnostics  

Could CereVasc’s eShunt replace VP shunts in post-aneurysmal hydrocephalus treatment?

CereVasc completes ETCHES trial enrollment for its eShunt device in post-SAH hydrocephalus. Learn what this means for future neurosurgical care.

Recent Posts

  • Medtronic’s SPR Therapeutics deal signals a sharper move into earlier chronic pain intervention
  • Why Donor Alliance and LifeSource are building a new model for transplant system performance
  • Papillary NMIBC could become the next commercial test for ImmunityBio’s ANKTIVA franchise
  • Is Avvio Medical building the next outpatient frontier in kidney stone and ureteral stone therapy?
  • Phoenix and Raven launch direct-to-patient generic semaglutide after Health Canada approval
  • How Codexis, Inc.’s ECO Synthesis platform could reshape industrial RNA production workflows
  • How the PharmAla Biotech Holdings Inc. and Jupiter Neurosciences, Inc. deal reflects changing investor expectations in psychedelics
  • Could Hyundai Bioscience’s XAFTY become a crisis-response antiviral for Ebola and hantavirus?
  • How Araceli Biosciences is pushing live-cell imaging into ultra-high-throughput drug screening
  • Regeneron’s $2.2bn Parabilis pact signals rising interest in next-generation conjugates
  • Samsung Bioepis targets Japan’s autoimmune market with ustekinumab biosimilar debut
  • Bayer’s asundexian FDA priority review puts Factor XIa inhibition closer to a real stroke prevention test
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes